- Home
- BMRN vs KGC Comparison
BMRN vs KGC Comparison
Compare BMRN & KGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- KGC
- Stock Information
- Founded
- BMRN 1996
- KGC 1993
- Country
- BMRN United States
- KGC Canada
- Employees
- BMRN N/A
- KGC N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- KGC Precious Metals
- Sector
- BMRN Health Care
- KGC Basic Materials
- Exchange
- BMRN Nasdaq
- KGC Nasdaq
- Market Cap
- BMRN 13.7B
- KGC 12.0B
- IPO Year
- BMRN 1999
- KGC N/A
- Fundamental
- Price
- BMRN $71.44
- KGC $12.49
- Analyst Decision
- BMRN Buy
- KGC Buy
- Analyst Count
- BMRN 22
- KGC 3
- Target Price
- BMRN $94.00
- KGC $11.00
- AVG Volume (30 Days)
- BMRN 1.5M
- KGC 19.8M
- Earning Date
- BMRN 04-23-2025
- KGC 05-06-2025
- Dividend Yield
- BMRN N/A
- KGC 0.96%
- EPS Growth
- BMRN 153.71
- KGC 126.95
- EPS
- BMRN 2.21
- KGC 0.77
- Revenue
- BMRN $2,853,915,000.00
- KGC $5,148,800,000.00
- Revenue This Year
- BMRN $12.23
- KGC $9.91
- Revenue Next Year
- BMRN $9.90
- KGC N/A
- P/E Ratio
- BMRN $32.37
- KGC $16.22
- Revenue Growth
- BMRN 17.97
- KGC 21.44
- 52 Week Low
- BMRN $60.63
- KGC $6.13
- 52 Week High
- BMRN $94.85
- KGC $12.90
- Technical
- Relative Strength Index (RSI)
- BMRN 55.89
- KGC 65.37
- Support Level
- BMRN $69.60
- KGC $12.12
- Resistance Level
- BMRN $73.18
- KGC $12.59
- Average True Range (ATR)
- BMRN 1.64
- KGC 0.36
- MACD
- BMRN -0.15
- KGC 0.07
- Stochastic Oscillator
- BMRN 63.45
- KGC 81.46
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.
About KGC Kinross Gold Corporation
Kinross Gold is a Canada-based gold producer, producing roughly 2.2 million gold equivalent ounces in 2023. The company had about a decade of gold reserves at the end of 2023. It operates mines in the Americas and West Africa after selling its low-cost Russian operations in 2022 in response to the invasion of Ukraine. The company has historically used acquisitions to fuel expansion into new regions and production growth. In 2022, Kinross purchased the Great Bear project in Canada, which, if developed, could produce an average of more than 500,000 ounces of gold per year for at least a decade.